Results 151 to 160 of about 3,006,184 (303)

Differentiation of blast cells from a Down's syndrome patient with transient myeloproliferative disorder [PDF]

, 1987
J Suda, M Eguchi, Y Akiyama, Y Iwama, T Furukawa, Y Sato, Y Miura, T Suda, M Saito   +8 more
openalex   +1 more source

Outcomes of Cerebral Venous Thrombosis in Patients With Myeloproliferative Neoplasms from a U.S. Nationwide Hospitalization Study

eJHaem, Volume 7, Issue 1, February 2026.
Nikhil Vojjala, Raj Shah, Viktoriya Gibatova, Lakshmi Kattamuri, Shubham Agrawal, Geetha Krishnamoorthy, Rushad Patell   +6 more
wiley   +1 more source

Metformin Downregulates the STAT Pathway and Reduces Bone Marrow Fibrosis in Primary Myelofibrosis Patients: Final Results of the Phase II FIBROMET Trial

Hematological Oncology, Volume 44, Issue 1, January 2026.
ABSTRACT Primary myelofibrosis (PMF) is a chronic myeloproliferative neoplasm characterized by the activation of the JAK‐STAT pathway. Previous evidence showed that metformin might be a possible therapeutic option for treating JAK2‐mediated myeloproliferative neoplasms.
Paula de Melo Campos, Kátia Borgia Barbosa Pagnano, Fernanda Soares Niemann, Rubia Isler Mancuso, Fernanda Isabel Della Via, Ada Congrains, Juan Luiz Coelho‐Silva, Ângela Condotta Tinoco, Guilherme Rossi Assis‐Mendonça, Leandro Luiz Lopes de Freitas, Fabiola Traina, Sara T. Olalla Saad   +11 more
wiley   +1 more source

Myelodysplastic/Myeloproliferative Neoplasm in a Dog: A Case Report

Veterinary Medicine and Science, Volume 12, Issue 1, January 2026.
This is a bone marrow aspirate smear image from an 18‐year‐old mixed‐breed dog diagnosed with myelodysplastic/myeloproliferative neoplasm. Both peripheral blood and bone marrow examinations revealed marked myeloid hyperplasia and dysplastic changes. ABSTRACT Myelodysplastic syndrome/myeloproliferative neoplasm (MDS/MPN) is a clonal myeloid disorder ...
Sumin Cha, DoHyeon Yu, Hyeona Bae
wiley   +1 more source

Mapping VEXAS‐associated and rare UBA1 variants in the United Kingdom: Insights from patient cohorts and the general population

British Journal of Haematology, Volume 208, Issue 1, Page 116-128, January 2026.
VEXAS syndrome is a late‐onset inflammatory disorder with rheumatological and haematological features. Epidemiological studies of VEXAS syndrome so far have been limited. Analysis of various UK cohorts estimates the incidence of VEXAS to be 1.51/100 000, or 171 new cases in the population of men over the age of 50 who are being investigated for myeloid
Ana Martinez Rodriguez, Leon Chang, Dorota Rowczenio, Alexandra Smith, Ebun Omoyinmi, James A. Poulter, Andrew McGregor, Sebastian Francis, Roochi Trikha, Adam Al‐Hakim, Kar Lok Kong, David G. Kent, Helen Lachmann, Austin Kulasekararaj, Catherine Cargo, Sinisa Savic   +15 more
wiley   +1 more source

Development and application of novel immunoassays for eosinophil granule major basic proteins to evaluate eosinophilia and myeloproliferative disorders. [PDF]

J Immunol Methods, 2021
Squillace DL, Checkel JL, Tefferi A, Kita H, Gleich GJ.   +4 more
europepmc   +1 more source

Impact of methotrexate‐dosing regimens for GVHD prophylaxis on clinical outcomes of HLA‐matched allogeneic HSCT

British Journal of Haematology, Volume 208, Issue 1, Page 219-228, January 2026.
Summary Severe graft‐versus‐host disease (GVHD) remains a major complication of allogeneic haematopoietic stem cell transplantation (allo‐HSCT), necessitating optimal immunosuppressive strategies. This retrospective study used data from the Japanese Transplant Registry Unified Management Program to compare three methotrexate (MTX)‐dosing regimens for ...
Tomotaka Suzuki, Tomoyasu Jo, Kota Yoshifuji, Tadakazu Kondo, Noriko Doki, Yoshinobu Kanda, Tetsuya Nishida, Yasushi Onishi, Noboru Asada, Takahiro Fukuda, Masashi Sawa, Yuta Hasegawa, Kentaro Serizawa, Shuichi Ota, Masatsugu Tanaka, Makoto Yoshimitsu, Yoshiko Atsuta, Junya Kanda   +17 more
wiley   +1 more source

Biomolecular and histological features in pediatric essential thrombocythemia: adequacy of who diagnostic criteria [PDF]

, 2017
Myeloproliferative neoplasms (MPN), Essential Thrombocythemia (ET), Polycythemia Vera (PV) and primary myelofibrosis (PMF), are clonal disorders of the hematopoietic stem cell.
Bertozzi, Irene
core   +1 more source

Lexicon for Clonal Hematopoiesis in Liquid Biopsy

Clinical and Translational Science, Volume 19, Issue 1, January 2026.
ABSTRACT Historically, clonal hematopoiesis (CH) has been recognized as a confounder of cell‐free DNA (cfDNA) testing. Recent evidence now demonstrates the role of CH as a risk factor in health, generating distinct sources of cfDNA that can be leveraged for liquid biopsy diagnostics.
Robert Tell, Ahmet Zehir, Andrew T. Anfora, Gargi Basu, Michelle Beidelschies, Carolyn Compton, Stephen Cristiano, James H. Godsey, John Hu, Donald J. Johann, Marisa Juntilla, Rina Kansal, Christine Lo, Dorys Lopez Ramos, Vaidhyanathan Mahaganapathy, David Merriam, Christian Rolfo, Hugh Russell, Usha Singh, Daniel Stetson, Martin You, Lauren C. Leiman   +21 more
wiley   +1 more source

Herpes Zoster in Hematological Disorders: Pathogenesis, Risk Stratification, and Emerging Strategies for Prevention and Immunization

European Journal of Haematology, Volume 116, Issue 1, Page 14-22, January 2026.
ABSTRACT Background Herpes zoster (HZ), resulting from reactivation of latent varicella‐zoster virus (VZV), imposes a significant burden on immunocompromised patients, particularly those with hematological malignancies and recipients of hematopoietic stem cell transplants (HSCT).
Enrica Antonia Martino, Ernesto Vigna, Antonella Bruzzese, Nicola Amodio, Eugenio Lucia, Virginia Olivito, Caterina Labanca, Santino Caserta, Francesco Mendicino, Fortunato Morabito, Massimo Gentile   +10 more
wiley   +1 more source